Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Incannex Healthcare Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Incannex Healthcare Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Anastassov George | Director | 2,456,677 | Nov 14, 2025 | 1 |
| Widdows Peter | Director | 1,957,803 | Nov 14, 2025 | 1 |
| Latham Joel | CEO and President | 24,186,177 | Nov 14, 2025 | 1 |
| Clark Robert | Director | 1,786,956 | Nov 14, 2025 | 1 |
| Valentine Troy | Director | 12,001,858 | Nov 14, 2025 | 1 |
| Swan Joseph | CFO, Treasurer and Secretary | 921,358 | Nov 14, 2025 | 1 |
| Barbato Luigi M. | Chief Medical Officer | 100,476 | Oct 24, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.